The modern GLP-1 era effectively began with semaglutides 2017 approval as Ozempic
For example, the UK SmPCs for liraglutide (Saxenda) and semaglutide (Wegovy/Ozempic), available via the Electronic Medicines Compendium (eMC), advise awareness of heart rate increases during treatment and recommend that clinicians consider discontinuation if a clinically relevant sustained rise in resting heart rate is observed
future studies will shed light on whether semaglutide can compete (or synergize) with non-GLP-1 drugs like resmetirom (Madrigal, 30% resolution at 52 weeks), efuxifermin (Akero) and Lanifibranor (Inventiva) that are in late stage clinical testing for NASH
Upper abdomen pain, stool that has a clay color, a fever, and signs of jaundice can signal the presence of gallbladder issues
NOVO WARNED ON PRICE PRESSURE On Wednesday, Novo said that pricing pressure was unprecedented as customers shifted to the cash-pay market and insurers demanded deep discounts after it agreed to lower prices at the request of the Trump Administration, forcing its shares to plummet